Successful revascularization of re-stenosis of lower extremity arteries with localized delivery of paclitaxel

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 2, 2008, Pages 294-298

  Latif, Faisal ^a   Hennebry, Thomas A ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Drug delivery; Paclitaxel; Peripheral vascular disease; Restenosis

Indexed keywords

PACLITAXEL;

ADULT; AGED; ANAMNESIS; ANGIOGRAPHY; ANGIOPLASTY; ARTERY GRAFT; ARTICLE; ATHERECTOMY; CASE REPORT; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; FEMALE; GUIDE WIRE; HUMAN; ILIAC ARTERY OBSTRUCTION; INTRAVASCULAR ULTRASOUND; LASER SURGERY; LEG REVASCULARIZATION; MALE; PERIPHERAL VASCULAR DISEASE; REPEAT PROCEDURE; RESTENOSIS; STENT; SUPERFICIAL FEMORAL ARTERY; SYMPTOMATOLOGY; VASCULAR ACCESS;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; PACLITAXEL; RECURRENCE; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 50849108841     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21598     Document Type: Article

References (13)

1. Deutschmann HA, Schoellnast H, Temmel W, Deutschmann M, Schwantzer G, Fritz GA, Brodmann M, Hausegger KA. Endoluminal therapy in patients with peripheral arterial disease: Prospective assessment of quality of life in 190 patients. Am J Roentgenol 2007;188:169-175.
2. Koppensteiner R, Spring S, Amann-Vesti BR, Meier T, Pfammatter T, Rousson V, Banyai M, van der Loo B. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: A randomized controlled trial. J Vasc Surg 2006;44:1247-1253.
3. Schainfeld RM. Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature. Catheter Cardiovasc Interv 2002;56:421-431.
4. Ellozy SH, Carroccio A. Drug-eluting stents in peripheral vascular disease: Eliminating restenosis. Mount Sinai J Med 2003;70: 417-419.
5. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, Badimon JJ, Fuster V, Corti R. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 2004;110:1156-1161.
6. Wahlgren CM, Sten-Linder M, Egberg N, Kalin B, Blohme L, Swedenborg J. The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease. Cardiovasc Intervent Radiol 2006;29:530-535.
7. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980;77:1561-1565.
8. Sollott SJ, Cheng L, Pauly RR, Jenkins GM, Monticone RE, Kuzuya M, Froehlich JP, Crow MT, Lakatta EG, Rowinsky EK, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995;95:1869-1876.
9. Straubinger RM, Sharma A, Murray M, Mayhew E. Novel Taxol formulations: Taxol-containing liposomes. Monogr Natl Cancer Inst 1993;15:69-78.
10. Jordan MA, Toso RJ, Thrower D, Wilson L. Mechansim of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA 1993;90:9552-9556.
11. Kohler TR, Toleikis PM, Gravett DM, Avelar RL. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh. J Vasc Surg 2007;45:1029-1038.
12. Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm BR, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-645.
13. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-699.